Come and meet us
Come and meet our experts, directors & CEOs who will share with you their day-to-day experience of the pharmaceutical industry.
Debiopharm Academy aims to promote constructive conversation between academia and industry, by sharing experiences and understanding of today’s challenges. Each Debiopharm Academy conference covers a specific topic focusing on the operational side of a development drug company such as: personalized medicine, drug manufacturing, new business models, project management, intellectual property or new drug screening.
Find on the map
Bacteriophages: an alternative to antibiotics?
Bacteriophages (phages) are viruses that infect bacterial hosts, and since their discovery over a century ago have been primarily exploited to control bacterial populations and to serve as tools in molecular biology. The success of emerging antibacterials in the 1940s led to a decline in phage therapy in the Western World. However, in the face of rising antibiotic resistance, therapeutic phages are alternatives to conventional antibiotics. The history, production, current preclinical and clinical bacteriophage research will be reviewed and the regulatory challenge of developing phage therapy discussed.
SpeakerJean-Maurice Dumont Ph.D.
Senior Scientific Director
Debiopharm International SA